Registration Dossier

Administrative data

Description of key information

No repeated dose toxicity data are available for the registered substance or any other members of the analogue group (see Section 1.4). A 90-day repeated dose toxicity study by the inhalation route is proposed.

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available (further information necessary)

Repeated dose toxicity: inhalation - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

No repeated dose toxicity data are available for the registered substance or any other members of the analogue group (see Section 1.4). A 90-day repeated dose toxicity study by the inhalation route is proposed.

Justification for classification or non-classification

In the absence of data there is no classification for repeated dose toxicity.